Sub-100nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification

• Published in: Chemical engineering science 2015-07, Vol.130, p.207-220
• Main Authors: Li, M., Yaragudi, N., Afolabi, A., Dave, R., Bilgili, E.
• Format: Article
• Language: English
• Subjects: Bead wear; Breakage kinetics; Microhydrodynamics; Process intensification; Sub-100 nm drug particles; Wet stirred media milling
• ISSN: 0009-2509; 1873-4405
• DOI: 10.1016/j.ces.2015.03.020

There is sustained interest in sub-100nm particles of poorly water-soluble drugs as such small particles offer improved permeation through various biological barriers and result in rapid onset of therapeutic action. An intensified wet stirred media milling process was developed here for fast production of sub-100nm drug particles with low bead contamination and reduced energy consumption. Griseofulvin and indomethacin, two model poorly water-soluble drugs, were wet-milled. Yttrium-stabilized zirconia beads with a nominal size ranging from 50µm to 800µm were used in the baseline process, which was subsequently intensified with the optimal bead size by increasing rotor tip speed, bead loading, and suspension flow rate stepwise, as guided by a microhydrodynamic model. Laser diffraction, dynamic light scattering, scanning electron microscopy, and XRD were used to characterize the milled suspensions. Results from the baseline process indicated that sub-100nm griseofulvin particles were only produced when 50 or 100µm beads were used in the 360min milling experiments. Interestingly, using 50µm beads led to the formation of sub-100nm griseofulvin particles within 240min with the lowest bead (zirconium) contamination and specific energy consumption. This could be explained though the microhydrodynamic model, revealing that 50µm beads led to the highest frequency of drug particle compressions yet generated the lowest bead contact pressure. The processing time was further reduced to as low as 64min producing griseofulvin particle size of 100nm through step-wise intensification of the milling process with the 50µm beads, as quantified by a milling intensity factor. Due to the enhancement of the breakage kinetics, the process intensification enabled shorter milling to attain 100nm particles, thus resulting in significant energy savings and low bead contamination despite an increase in power consumption. The general applicability of the process intensification method was confirmed through milling of indomethacin, which also led to sub-100nm particles faster with reduced energy consumption and low contamination. [Display omitted] •Sub-100nm drug particles via wet stirred media milling for enhanced dissolution.•Particle breakage, energy consumption, and bead wear investigated holistically.•A novel process intensification method with a microhydrodynamic model presented.•Optimal performance with the 50μm beads, whose use enables the intensification.•The new method led to sh